glp-1 news today obesity drug updates News: Latest on Weight Loss and Diabetes Medications GLP-1 Pharmacy Pricing Update (Dec

Another 2025 survey published in JAMA Health Forum noted that, should Medicare pay for the drugs, it could avoid spending a hypothetical $18.2 billion on obesity-related health expenditures over 10 years while dishing out $65.9 billion annually on the GLP-1s by year 10, thereby negating any savings

Phentermine Phentermine is approved for weight loss

Additionally, there were three articles assessed which suggested that because of the lack of significant difference in aspiration risk, there should be no difference in the continuation or withholding of GLP-1 RAs in the perioperative setting (Chang et al

1 Guidelines, manufacturers, and FDA warnings have erred on the side of caution and recommend careful use of GLP-1 RAs in patients with a history or high risk of pancreatitis

Accessed January 17, 2024.